Subretinal deposits in young patients treated with voretigene neparvovec-rzyl for RPE65-mediated retinal dystrophy. Lopez J, Borchert M, Lee TC, Nagiel A, et al. Br J Ophthalmol 2022 Jul 14. pii: bjo-2022-321488. doi: 10.1136/bjo-2022-321488.

Read + Share

Amedeo Smart

Independent Medical Education

Lopez J, Borchert M, Lee TC, Nagiel A, et al. Subretinal deposits in young patients treated with voretigene neparvovec-rzyl for RPE65-mediated retinal dystrophy. Br J Ophthalmol 2022 Jul 14. pii: bjo-2022-321488. doi: 10.1136/bjo-2022-321488.
PMID: 35835501